AR064419A1 - Composiciones farmaceuticas - Google Patents
Composiciones farmaceuticasInfo
- Publication number
- AR064419A1 AR064419A1 ARP070105696A ARP070105696A AR064419A1 AR 064419 A1 AR064419 A1 AR 064419A1 AR P070105696 A ARP070105696 A AR P070105696A AR P070105696 A ARP070105696 A AR P070105696A AR 064419 A1 AR064419 A1 AR 064419A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical compositions
- pharmaceutically acceptable
- pharmaceutical composition
- acceptable acid
- gelatin capsule
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una composicion farmacéutica en la forma de una cápsula de gelatina, la cual comprende un ácido farmacéuticamente aceptable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06126698 | 2006-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR064419A1 true AR064419A1 (es) | 2009-04-01 |
Family
ID=37890457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070105696A AR064419A1 (es) | 2006-12-20 | 2007-12-18 | Composiciones farmaceuticas |
Country Status (15)
Country | Link |
---|---|
US (1) | US20100068265A1 (es) |
EP (1) | EP2120889A1 (es) |
JP (1) | JP2010513351A (es) |
KR (1) | KR20090094373A (es) |
CN (1) | CN101563072A (es) |
AR (1) | AR064419A1 (es) |
AU (1) | AU2007334856A1 (es) |
BR (1) | BRPI0720489A2 (es) |
CA (1) | CA2672400A1 (es) |
CL (1) | CL2007003698A1 (es) |
MX (1) | MX2009006735A (es) |
PE (1) | PE20081482A1 (es) |
TW (1) | TW200833375A (es) |
UY (1) | UY30810A1 (es) |
WO (1) | WO2008074479A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5829607B2 (ja) * | 2010-06-30 | 2015-12-09 | 持田製薬株式会社 | ω3脂肪酸の配合製剤 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60239418A (ja) * | 1984-05-15 | 1985-11-28 | Nippon Kayaku Co Ltd | エトポシド軟カプセル製剤 |
DE4001622A1 (de) * | 1990-01-20 | 1991-07-25 | Thomae Gmbh Dr K | Orale arzneimittelformen von pimobendan |
US5620704A (en) * | 1994-11-07 | 1997-04-15 | Warner-Lambert Company | Process for stabilizing gelatin products |
US5726181A (en) * | 1995-06-05 | 1998-03-10 | Bionumerik Pharmaceuticals, Inc. | Formulations and compositions of poorly water soluble camptothecin derivatives |
WO1997033568A1 (en) * | 1996-03-12 | 1997-09-18 | Novartis Ag | Filled gelatin capsules having a reduced degree of cross-linking |
US6228894B1 (en) * | 1998-04-17 | 2001-05-08 | Enhanced Derm Technologies, Inc. | Softgel-compatible composition containing retinol |
AU2003231126A1 (en) * | 2002-04-25 | 2003-11-10 | Banner Pharmacaps, Inc. | Chewable soft capsule |
ES2524000T3 (es) * | 2002-06-05 | 2014-12-03 | Teva Czech Industries S.R.O. | Reducción de la reticulación de la gelatina |
-
2007
- 2007-12-14 PE PE2007001792A patent/PE20081482A1/es not_active Application Discontinuation
- 2007-12-18 MX MX2009006735A patent/MX2009006735A/es not_active Application Discontinuation
- 2007-12-18 WO PCT/EP2007/011138 patent/WO2008074479A1/en active Application Filing
- 2007-12-18 EP EP07856861A patent/EP2120889A1/en not_active Withdrawn
- 2007-12-18 JP JP2009541867A patent/JP2010513351A/ja active Pending
- 2007-12-18 CN CNA2007800472119A patent/CN101563072A/zh active Pending
- 2007-12-18 BR BRPI0720489-2A patent/BRPI0720489A2/pt not_active Application Discontinuation
- 2007-12-18 KR KR1020097014926A patent/KR20090094373A/ko not_active Application Discontinuation
- 2007-12-18 CA CA002672400A patent/CA2672400A1/en not_active Abandoned
- 2007-12-18 AU AU2007334856A patent/AU2007334856A1/en not_active Abandoned
- 2007-12-18 US US12/518,958 patent/US20100068265A1/en not_active Abandoned
- 2007-12-18 AR ARP070105696A patent/AR064419A1/es unknown
- 2007-12-19 UY UY30810A patent/UY30810A1/es not_active Application Discontinuation
- 2007-12-19 TW TW096148801A patent/TW200833375A/zh unknown
- 2007-12-19 CL CL200703698A patent/CL2007003698A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2010513351A (ja) | 2010-04-30 |
PE20081482A1 (es) | 2008-12-23 |
BRPI0720489A2 (pt) | 2014-02-04 |
US20100068265A1 (en) | 2010-03-18 |
CN101563072A (zh) | 2009-10-21 |
WO2008074479A1 (en) | 2008-06-26 |
KR20090094373A (ko) | 2009-09-04 |
AU2007334856A1 (en) | 2008-06-26 |
MX2009006735A (es) | 2009-06-30 |
EP2120889A1 (en) | 2009-11-25 |
CL2007003698A1 (es) | 2008-07-18 |
TW200833375A (en) | 2008-08-16 |
CA2672400A1 (en) | 2008-06-26 |
UY30810A1 (es) | 2008-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201290982A1 (ru) | Фармацевтические композиции, препятствующие злоупотреблению | |
CY1117021T1 (el) | Φαρμακευτικες συνθεσεις οι οποιες περιεχουν νιλοτινιβη ή αλας αυτης | |
DK2254549T3 (da) | Vandige farmaceutiske sammensætninger, indeholdende borat-polyol-komplekser | |
BRPI0511900A (pt) | composições farmacêuticas | |
BRPI0810646A2 (pt) | " compostos farmacêuticos ". | |
DE602007003074D1 (de) | Neue pyrinderivate | |
HN2006014095A (es) | Forma cristalina ortorrombica del maleato de asenapina | |
BRPI0820997A2 (pt) | Comprimidos de desintegração oral compreendendo difenidramina. | |
WO2008131114A3 (en) | Pharmaceutical formulations containing lipoic acid derivatives | |
WO2006138735A3 (en) | Gel compositions for topical administration | |
WO2007143651A3 (en) | Chewable co-enzyme q-10 capsule | |
NO20085302L (no) | Farmasoytisk preparat omfattende Amlodipin og Losartan | |
DK2033629T3 (da) | Fast farmaceutisk sammensætning omfattende valsartan | |
AR033711A1 (es) | Composiciones farmaceuticas | |
JP2009537554A5 (es) | ||
EA201170512A1 (ru) | Композиция для перорального введения | |
TNSN07337A1 (en) | Pharmaceutical composition comprising an indolylmaleimide derivative | |
EA201000039A1 (ru) | Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль | |
CL2007003593A1 (es) | Composicion farmaceutica que comprende fluoresceina pura; procedimiento de preparacion de la fluoresceina. | |
BRPI0610156A2 (pt) | forma micronizada de um composto, forma purificada i do composto, kit, padrão de referência, e, método de preparaçao de uma composição farmacêutica. | |
SM200500011B (it) | Una composizione farmaceutica antimicobatterica | |
IT1401284B1 (it) | Nuove formulazioni farmaceutiche idonee per la somministrazione orale di esomeprazolo magnesio diidrato, in forma di compresse mups (multi unit pellets system). | |
ITFI20080016A1 (it) | Formulazioni farmaceutiche orali contenenti gliclazide. | |
ATE533477T1 (de) | Pharmazeutische zusammensetzungen enthaltend irbesartan | |
AR064419A1 (es) | Composiciones farmaceuticas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |